Please assess the completion status of the following clinical trial:

Trial Title: Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient must be seen at the St. Louis Children's Hospital NF Clinic~* Diagnosis of NF1~* Between 1 and 7 years of age, inclusive~* Diagnosed with hypotonia~* Legally authorized representative/guardian must be able to understand and willing to sign an IRB-approved informed consent document~* Must have an MRI scan ordered by a treating physician~Exclusion Criteria:~* Normal tone on clinical exam~* Known allergy to gadolinium or the sedative, propofol, used during MRI~* Poor kidney function defined as a known renal disease or elevated BUN and creatine~* Requiring intubation for anesthesia

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 7 Years
- Healthy Volunteers: f

Study Arms:
- Arm 1: MRI of brain with gadolinium contrast (Type: EXPERIMENTAL): -Eligible children whose guardians have consented to their participation will undergo routine clinical brain MRI with gadolinium contrast. The MRI scan will last no more than 45 minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).